Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

CompletedOBSERVATIONAL
Enrollment

441

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Rheumatoid Arthritis
Trial Locations (23)

100

Pfizer Investigational Site, Taipei TOC

116

Pfizer Investigational Site, Taipei

204

Pfizer Investigational Site, Keelung

220

Pfizer Investigational Site, Taipei

330

Pfizer Investigational Site, Taoyuan District

333

Pfizer Investigational Site, Taoyuan District

402

Pfizer Investigational Site, Taichung

407

Pfizer Investigational Site, Taichung

427

Pfizer Investigational Site, Taichung

500

Pfizer Investigational Site, Changhua

Pfizer Investigational Site, Changhua

622

Pfizer Investigational Site, Dalin

807

Pfizer Investigational Site, Kaohsiung City

10630

Pfizer Investigational Site, Taipei

11042

Pfizer Investigational Site, Taipei

14409

Pfizer Investigational Site, Taipei

33305

Pfizer Investigational Site, Guishanli

50544

Pfizer Investigational Site, Lukang Zhen

61363

Pfizer Investigational Site, Putz

70428

Pfizer Investigational Site, Tainan City

81346

Pfizer Investigational Site, Kaohsiung City

83301

Pfizer Investigational Site, Niao Sung Hsiang

97002

Pfizer Investigational Site, Hualien City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00888576 - Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan | Biotech Hunter | Biotech Hunter